2025
SJR Q2
JCR Q3 · 2,4
68 eşleşen makale
SCIE
Dergi ayrıntısı
Psychiatry Research - Neuroimaging
- Yayıncı
- Elsevier Ireland Ltd
- Ülke
- Ireland · Western Europe
- Tür
- journal
- ISSN
-
0925492718727506
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,819
- Quartile Q2
- H-Index 128
- Atıf/yayın 2,66
- Doküman (3y) 301
- Atıf (3y) 839
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,4
- 5Y JIF 2,5
- JCI 0,62
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Neuroscience (miscellaneous) Q2
- Psychiatry and Mental Health Q2
- Radiology, Nuclear Medicine and Imaging Q2
Alanlar
- Medicine
- Neuroscience
WoS kategorileri
- Clinical Neurology | Neuroimaging | Psychiatry
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,819 | 2,4 | 2,5 | 0,62 | Q3 | 128 |
| 2024 | Q1 | Q3 | 1,186 | 2,1 | 2,3 | 0,61 | Q3 | 124 |
| 2023 | Q1 | Q3 | 0,797 | 2,1 | 2,3 | 0,57 | Q3 | 124 |
| 2022 | Q1 | Q3 | 0,813 | 2,3 | 2,5 | 0,57 | Q3 | 124 |
| 2021 | Q2 | Q3 | 0,817 | 2,5 | 2,8 | 0,58 | Q3 | 124 |
| 2020 | Q1 | Q3 | 1,03 | 2,4 | 2,9 | 0,62 | Q3 | 124 |
| 2019 | Q1 | Q3 | 1,131 | 2,1 | 2,5 | 0,67 | Q3 | 124 |
| 2018 | — | Q3 | — | 2,3 | 2,7 | 0,73 | Q2 | — |
| 2017 | Q1 | Q2 | 1,412 | 2,5 | 2,9 | 0,76 | Q2 | 124 |
| 2016 | Q1 | Q3 | 1,6 | 1,9 | 2,7 | — | — | 124 |
| 2015 | Q1 | Q2 | 1,758 | 2,5 | 3,2 | — | — | 124 |
| 2014 | Q1 | Q2 | 1,692 | 2,4 | 3,4 | — | — | 124 |
| 2013 | Q1 | Q2 | 2,113 | 2,8 | 3,4 | — | — | 124 |
| 2012 | Q1 | Q1 | 2,123 | 3,4 | 3,8 | — | — | 124 |
| 2011 | Q1 | Q1 | 1,855 | 3 | 3,3 | — | — | 124 |
| 2010 | Q1 | Q2 | 2,081 | 2,1 | 3,1 | — | — | 124 |
| 2009 | — | Q1 | — | 3,4 | 4 | — | — | — |
| 2008 | — | Q2 | — | 2,6 | 3,6 | — | — | — |
| 2007 | — | Q2 | — | 2,3 | 3,2 | — | — | — |
| 2006 | — | Q1 | — | 2,8 | — | — | — | — |
| 2005 | — | Q1 | — | 2,7 | — | — | — | — |
| 2004 | — | Q2 | — | 2,2 | — | — | — | — |
| 2003 | — | Q1 | — | 2,6 | — | — | — | — |
| 2002 | — | Q2 | — | 2,2 | — | — | — | — |
| 2001 | — | Q1 | — | 2,4 | — | — | — | — |
| 2000 | — | Q2 | — | 1,9 | — | — | — | — |
| 1999 | — | Q2 | — | 2,2 | — | — | — | — |
| 1998 | — | Q2 | — | 1,3 | — | — | — | — |
| 1997 | — | Q1 | — | 2,2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 168/296 |
| 2025 | NEUROIMAGING | SCIE | Q3 | Q3 | 13/18 |
| 2025 | PSYCHIATRY | SCIE | Q3 | Q3 | 151/293 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 167/286 |
| 2024 | NEUROIMAGING | SCIE | Q3 | Q3 | 12/16 |
| 2024 | PSYCHIATRY | SCIE | Q3 | Q3 | 165/288 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 163/280 |
| 2023 | NEUROIMAGING | SCIE | Q3 | Q3 | 10/15 |
| 2023 | PSYCHIATRY | SCIE | Q3 | Q3 | 148/279 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 151/212 |
| 2022 | NEUROIMAGING | SCIE | Q3 | Q3 | 10/14 |
| 2022 | PSYCHIATRY | SCIE | Q3 | Q3 | 115/155 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 155/212 |
| 2021 | NEUROIMAGING | SCIE | Q3 | Q3 | 10/14 |
| 2021 | PSYCHIATRY | SCIE | Q4 | Q3 | 120/155 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 150/208 |
| 2020 | NEUROIMAGING | SCIE | Q3 | Q3 | 10/14 |
| 2020 | PSYCHIATRY | SCIE | Q3 | Q3 | 114/156 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 139/204 |
| 2019 | NEUROIMAGING | SCIE | Q4 | Q3 | 11/14 |
| 2019 | PSYCHIATRY | SCIE | Q3 | Q3 | 99/155 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 121/199 |
| 2018 | NEUROIMAGING | SCIE | Q3 | Q2 | 9/14 |
| 2018 | PSYCHIATRY | SCIE | Q3 | Q2 | 79/146 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 110/197 |
| 2017 | NEUROIMAGING | SCIE | Q3 | Q2 | 8/14 |
| 2017 | PSYCHIATRY | SCIE | Q2 | Q2 | 69/142 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 129/194 |
| 2016 | NEUROIMAGING | SCIE | Q3 | — | 10/14 |
| 2016 | PSYCHIATRY | SCIE | Q3 | — | 86/142 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 89/193 |
| 2015 | NEUROIMAGING | SCIE | Q3 | — | 8/14 |
| 2015 | PSYCHIATRY | SCIE | Q2 | — | 61/142 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 87/192 |
| 2014 | NEUROIMAGING | SCIE | Q3 | — | 8/14 |
| 2014 | PSYCHIATRY | SCIE | Q2 | — | 63/140 |
| 2013 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 67/194 |
| 2013 | NEUROIMAGING | SCIE | Q2 | — | 6/14 |
| 2013 | PSYCHIATRY | SCIE | Q2 | — | 53/136 |
| 2012 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 47/193 |
| 2012 | NEUROIMAGING | SCIE | Q1 | — | 3/14 |
| 2012 | PSYCHIATRY | SCIE | Q2 | — | 37/135 |
| 2011 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 61/192 |
| 2011 | NEUROIMAGING | SCIE | Q1 | — | 3/14 |
| 2011 | PSYCHIATRY | SCIE | Q2 | — | 41/130 |
| 2010 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 90/185 |
| 2010 | NEUROIMAGING | SCIE | Q2 | — | 5/14 |
| 2010 | PSYCHIATRY | SCIE | Q2 | — | 64/128 |
| 2009 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 41/167 |
| 2009 | NEUROIMAGING | SCIE | Q1 | — | 3/13 |
| 2009 | PSYCHIATRY | SCIE | Q2 | — | 36/117 |
| 2008 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 55/156 |
| 2008 | NEUROIMAGING | SCIE | Q2 | — | 4/12 |
| 2008 | PSYCHIATRY | SCIE | Q2 | — | 43/101 |
| 2007 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 63/146 |
| 2007 | NEUROIMAGING | SCIE | Q2 | — | 5/13 |
| 2007 | PSYCHIATRY | SCIE | Q2 | — | 43/94 |
| 2006 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 37/147 |
| 2006 | NEUROIMAGING | SCIE | Q1 | — | 3/13 |
| 2006 | PSYCHIATRY | SCIE | Q2 | — | 33/94 |
| 2005 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 36/148 |
| 2005 | NEUROIMAGING | SCIE | Q1 | — | 3/14 |
| 2005 | PSYCHIATRY | SCIE | Q2 | — | 35/94 |
| 2004 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 50/140 |
| 2004 | NEUROIMAGING | SCIE | Q2 | — | 5/14 |
| 2004 | PSYCHIATRY | SCIE | Q2 | — | 38/90 |
| 2003 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 33/135 |
| 2003 | NEUROIMAGING | SCIE | Q2 | — | 5/13 |
| 2003 | PSYCHIATRY | SCIE | Q2 | — | 30/87 |
| 2002 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 37/138 |
| 2002 | NEUROIMAGING | SCIE | Q2 | — | 5/13 |
| 2002 | PSYCHIATRY | SCIE | Q2 | — | 32/88 |
| 2001 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 30/136 |
| 2001 | NEUROIMAGING | SCIE | Q2 | — | 4/15 |
| 2001 | PSYCHIATRY | SCIE | Q2 | — | 25/81 |
| 2000 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 41/137 |
| 2000 | NEUROIMAGING | SCIE | Q2 | — | 5/15 |
| 2000 | PSYCHIATRY | SCIE | Q2 | — | 31/82 |
| 1999 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 37/132 |
| 1999 | PSYCHIATRY | SCIE | Q2 | — | 21/80 |
| 1998 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 51/125 |
| 1998 | PSYCHIATRY | SCIE | Q2 | — | 33/77 |
| 1997 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 19/107 |
| 1997 | PSYCHIATRY | SCIE | Q1 | — | 15/67 |